2010
November
April
March
Dr Chris Torrance
Chief Scientific Officer at Horizon Discovery
Chris has significant oncology research and development experience, including six years as a senior manager at Cambridge-based pharmaceutical company, Vernalis. His principle expertise lies in cancer cell biology and drug discovery. In this field, he has led project teams taking drug targets from inception through to hit identification, lead optimisation and into preclinical studies.
Chris holds a PhD from East Carolina University and completed a Post-Doctoral position in the world renowned oncology laboratory of Professor Bert Vogelstein (Johns Hopkins University) where he pioneered the use of X-MAN™ cancer models in high-throughput screening and drug discovery.
He spoke about his career, and how he started his own biotech (HD.)
Ken Farquhar
Science Communicator
Nick Montague
BBSRC Enterprise Fellow